Synexus® has appointed Dr. Sándor Kis country manager of Hungary.
Dr. Kis will be responsible for clinical trials at Synexus®'s hub site in Budapest, and the development of business in Hungary.
Dr. Kis specialised as a chest physician and has particular expertise in COPD, Asthma and other pulmonary conditions. He also undertook a three year management diploma in the UK.
Working for a variety of major pharma companies he has extensive expertise in clinical trials and in marketing.
The Hungarian clinical hub site, which is part of a network of Synexus® sites across Eastern Europe, is involved in several major studies for big pharma as well as a raft of smaller studies.
Hungary is proving to be one of the most attractive countries for Synexus® in the running of clinical trials as the hub site has good access to hundreds of thousands of patients.
All employees employed at the hub site are GCP trained.
Synexus® background
Synexus® headquartered in Manchester, England, is the world's largest multi-national company dedicated to the recruitment and running of late stage clinical trials.
Synexus® recruits participants for clinical trials on behalf of pharmaceutical, biotech and CROs. The clinical trials are then run and managed by Synexus® at 14 hub sites across the UK, Poland, Hungary, Bulgaria, India and South Africa.
Synexus® pioneered the running of clinical trials at hub sites as against the traditional method of contracting with primary care physicians, who on average only recruit and manage five patients each.
Synexus® currently has more than ten thousand patients enrolled in clinical trials.